Bayesian Capital Management’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
HL
WGI
SIM
RL
Bayesian Capital Management's ABEV Position: Q3 2022 in Review
Bayesian Capital Management sold out of Ambev (ABEV) in Q3 2022, closing a stake of 123,600 shares — an estimated $310K sold.
Bayesian Capital Management first reported a position in ABEV in Q4 2019 and held it in 3 quarters. The position peaked at $310K in Q2 2022. 295 funds tracked by Wall St. Rank hold ABEV as of Q3 2022.
- Bayesian Capital Management reported no remaining Ambev position as of Q3 2022 after selling out during the quarter.
- Bayesian Capital Management sold 123,600 Ambev shares in Q3 2022, an estimated $310K.
- Bayesian Capital Management first reported a position in Ambev in Q4 2019 and held it in 3 quarters.
- Bayesian Capital Management's Ambev position peaked at $310K in Q2 2022.
- 295 funds tracked by Wall St. Rank held Ambev as of Q3 2022.
Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.